New anthrax vaccine under development
May 31, 2016
Standard-Times - Back in 2012, the federal government picked Texas A&M University
as home to a new biosecurity center — one of three U.S. sites expected to play a key
role in developing and manufacturing drugs to fight bioterrorist threats, pandemic
influenza and other infectious diseases.
Vickie Sutton, a law professor at Texas Tech University and the director at the school's
Center for Biodefense, Law and Public Policy, said the work of the Texas A&M center
complements the Center for Biodefense and Emerging Infectious Diseases at the University
of Texas Medical Branch.
Read the story here.